Apollo
metadata only
Evaluating the Business Case for Continuous Manufacturing of Pharmaceuticals: A Supply Network perspective
This chapter addresses the challenges of evaluating the business case for continuous manufacturing of pharmaceuticals, looking beyond traditional technical assessments made at the unit operations or individual production facility level. It provides an overview of key concepts, approaches and tools f
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Business Model Options for Antibiotics: Learning from Other Industries#179782
- Aspects of the Pharmaceutical Business Model: Implications for Australia#1026053
- 21 U.S.C. § 399h — National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing#577202
- Predicting pharmacy choice for managed care network design.#247561
- Alliance Opportunities for Aus Biotech#1026047
Record · ID 1110948
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive